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Shiga toxineproducing Escherichia coli (STEC) is one of the major causes of human gastrointestinal
disease and has been implicated in sporadic cases and outbreaks of diarrhoea, haemorrhagic colitis and
haemolytic uremic syndrome worldwide. In this study, we determined the molecular characteristics and
phylogenetic relationship of STEC isolates, and their genetic diversity was compared to that of other
E. coli populations. Whole genome sequencing was performed on 132 clinical STEC isolates obtained from
the faeces of 129 Dutch patients with gastrointestinal complaints. STEC isolates of this study belonged to
44 different sequence types (STs), 42 serogenotypes and 14 stx subtype combinations. Antibiotic resis-
tance genes were more frequently present in stx1-positive isolates compared to stx2 and stx1 þ stx2
epositive isolates. The iha, mchB, mchC, mchF, subA, ireA, senB, saa and sigA genes were signiﬁcantly more
frequently present in eae-negative than in eae-positive STEC isolates. Presence of virulence genes
encoding type III secretion proteins and adhesins was associated with isolates obtained from patients
with bloody diarrhoea. Core genome phylogenetic analysis showed that isolates clustered according to
their ST or serogenotypes irrespective of stx subtypes. Isolates obtained from patients with bloody
diarrhoea were from diverse phylogenetic backgrounds. Some STEC isolates shared common ancestors
with non-STEC isolates. Whole genome sequencing is a powerful tool for clinical microbiology, allowing
high-resolution molecular typing, population structure analysis and detailed molecular characterization
of strains. STEC isolates of a substantial genetic diversity and of distinct phylogenetic groups were
observed in this study. M. Ferdous, CMI 2016;22:642.e1e642.e9
© 2016 The Authors. Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and
Infectious Diseases. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Shiga toxineproducing Escherichia coli (STEC) is a pathogen of
signiﬁcant public health concern associated with both outbreaksnt of Medical Microbiology,
er Groningen, HPC EB 80,
Ltd on behalf of European Society
g/licenses/by-nc-nd/4.0/).and sporadic cases of human gastrointestinal illness worldwide [1].
Enterohaemorrhagic E. coli, a subpopulation of STEC, can cause
bloody diarrhoea in humans, and some can cause haemolytic-
uremic syndrome [2]. The ability of STEC to cause disease is asso-
ciated with the production of Shiga-like toxins (Stx), which are
classiﬁed into two major types, Stx1 and Stx2 (encoded by the stx1
and stx2 genes). Stx1 and Stx2 are further categorized into several
subtypes; according to the new classiﬁcation proposed by Scheutz
et al. [3], Stx1 consists of three variants, Stx1a, Stx1c and Stx1d,
whereas Stx2 is a diverse group composed of seven distinct variants,of Clinical Microbiology and Infectious Diseases. This is an open access article under
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duction of Stx might not be solely responsible for pathogenesis of
STEC [4]; several mobile genetic elements, e.g. plasmids, trans-
posons, phages and pathogenicity islands, also play a role in disease
outcome [4,5]. One of the major virulence factors is the outer
membrane protein intimin, encoded by eae gene, which is part of a
pathogenicity island named the locus of enterocyte effacement (LEE)
[6]. Intimin is thought to be the genetic determinant of the forma-
tion of attaching and effacing (A/E) lesions, which is characterized by
the intimate attachment of the bacteria to the enterocyte membrane
and by the effacement of the microvilli of the enterocyte [6].
More than 100 O serotypes (based on the somatic antigen) of
STEC have been associated with human disease [7], with STEC
O157:H7 being the predominant serotype implicated in foodborne
infections worldwide and the cause of outbreaks in many coun-
tries, including Canada, Japan, the United Kingdom and the United
States [8]. However, several non-O157 STEC types have also been
associated with sporadic cases and outbreaks. Six O serotypes
(O26, O111, O103, O121, O45 and O145) have been reported by the
US Centers for Disease Control and Prevention as the cause of 71%
of non-O157 STEC infection, and these serotypes are considered as
the top six STEC [7]. Moreover, in Europe, infections caused by
non-O157 STEC strains are more common than those caused by
O157:H7 strains [8].
Different methods have been used to classify STEC. Karmali et al.
[9] introduced seropathotypes to assess the pathogenic potential of
STEC on the basis of their reported frequencies in human illness.
Subsequently, the classiﬁcationwas modiﬁed by the European Food
Safety Authority on the basis of the health outcome of reported
conﬁrmed human verotoxigenic E. coli cases. For epidemiologic
purposes, various genetic ﬁngerprinting methods have been
developed to identify, trace and prevent dissemination of STEC [10].
Among the sequence-based methods, multilocus sequence typing
(MLST) is a reliable method to determine genetic relatedness of
epidemiologically unrelated isolates, but it has limited discrimi-
natory power [11]. Currently whole genome sequencing (WGS) of
bacterial genomes is an accessible and affordable method [12,13].
An obvious application for WGS is epidemiologic typing to detect
and support outbreak investigations, to deﬁne transmission path-
ways of pathogens and to reveal laboratory cross-contamination
[14]. Because of the public health importance of STEC infections,
epidemiologic and molecular surveillance systems are essential for
early outbreak detection and to differentiate STEC strains based on
their potential to cause severe illness in humans [15,16].
This study was performed to determine the molecular charac-
teristics, phylogenetic relationship and diversity of STEC isolates
from faeces of patients obtained from two regions in the
Netherlands and to reveal the relation between molecular de-
terminants and disease outcome.
Methods
Collection of isolates
A multicentre prospective study, STEC-ID-net, was performed
during the period fromApril 2013 toMarch2014 in theDutch regions
of Groningen and Rotterdam. Stool samples from patients with sus-
pected infectious gastroenteritis were screened using quantitative
PCR targeting the stx1/stx2/escV genes, and positive samples were
further processed to obtain pure stx-positive isolates [17].
Phenotypic antibiotic resistance pattern
Antibiotic resistance patterns of the STEC isolates were deter-
mined using VITEK2 (bioMerieux, Marcy l’Etoile, France) followingEuropean Committee on Antimicrobial Susceptibility Testing
guidelines.
Whole genome sequencing
To perform the WGS of stx-positive isolates, DNA was extracted
using the UltraClean microbial DNA isolation kit (MO BIO Labora-
tories, Carlsbad, CA, USA) according to the manufacturer's protocol.
A DNA library was prepared using the Nextera XT kit (Illumina, San
Diego, CA, USA) according to the manufacturer's instructions, then
run on a MiSeq (Illumina) for generating paired-end 250 bp reads,
aiming at a coverage of at least 60-fold.
Data analysis and molecular characterization
De novo assembly was performed using CLC Genomics Work-
bench 7.0.3 (CLC Bio, Aarhus, Denmark) after quality trimming
(Qs  28) with optimal word sizes based on the maximum N50
value [18]. The average N50 value of the sequenced 132 STEC iso-
lates was 144166 (range, 23 341e387 919), and the average number
of contigs was 178 (range, 59e497). Gene annotation was per-
formed by uploading the assembled genome onto the RAST server
version 2.0 [19]. The sequence types (STs) and O and H serogeno-
types were identiﬁed by uploading the assembled genomes to the
MLST Finder 1.7 [20] and SerotypeFinder 1.1 tool [21], respectively,
of the Center for Genomic Epidemiology (CGE) website. The viru-
lence genes and stx subtypes were determined using CGE Viru-
lenceFinder 1.2 [22], and antibiotic resistance genes were
determined by CGE ResFinder 2.1 [23]. For the CGE server, the
threshold of ID was set to 85% and the percentage of minimum
overlapping gene length to 60%. The sequences assigned unknown
ST by CGE MLST ﬁnder were submitted to the EnteroBase database
of the University of Warwick.
This whole-genome shotgun project has been deposited in Na-
tional Center for Biotechnology Information (NCBI) under Bio-
Project PRJNA285020. The GenBank accession numbers are listed in
Supplementary Table S1.
Statistical analysis
To determine the association of virulence genes with different
patient groups and to compare the presence of virulence genes in
eae-positive and -negative STEC isolates, the Pearson chi-square
test was used. To observe the effect of the virulence genes on pa-
tient groups, univariate binary logistic regression was performed.
All analyses were done using two-tailed tests at a 5% signiﬁcance
level. The statistical analyses were performed using IBM SPSS Sta-
tistics 22 (IBM SPSS, Chicago, IL, USA).
Phylogenetic analysis of STEC isolates
To determine the phylogenetic relationship of the isolates, a
gene-by-gene approach was performed by SeqSphereþ 3.0 (Ridom,
Münster, Germany). Brieﬂy, an ad hoc core genome MLST (cgMLST)
scheme was developed using the genome of E. coli O157:H7 strain
Sakai (accession no. NC_002695) as the reference genome and an
additional ten E. coli as query genomes (Supplementary File S2) to
extract open reading frames (ORFs) from the genome of each
isolate using MLSTþ Target Deﬁner 2.1.0 of SeqSphereþ. Only the
ORFs without premature stop codons and ambiguous nucleotides
from contigs of assembled genomes were included. The genes
shared by all isolates analysed were deﬁned as the core genome
for phylogenetic analysis [18]. A neighbour-joining (NJ) tree was
constructed on the basis of a distance matrix among the isolates,
depending on the core genome of all isolates. To compare the
Fig. 1. Distribution of different serogenotypes (a), sequence types (STs) (b) and stx subtype combinations (c) among STEC isolates. *Other serogenotypes and STs of all isolates are
summarized in Supplementary Table S1.
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STEC (E. coli strain Sakai, strain EDL933, strain 11368, strain 2011c-
3493 and strain 12009) available on NCBI were included in the
phylogenetic analysis. To see the allele differences among the
isolates, a minimum spanning tree (MST) was constructed by
SeqSphereþ based on the numerical allele type for each isolates
according to the sequence identity of each gene [24]. An additional
NJ tree based on the accessory genome of the isolates was also
constructed.
Phylogenetic comparison of STEC isolates with diarrhoeagenic E. coli
(DEC) reference collection
The phylogenetic relationship of the STEC isolates of this study
with isolates of the DEC reference collection (n ¼ 76) [25] was
determined by cgMLST. The DEC consists of predominant clones of
diarrhoeagenic E. coli, including 27 STEC, 25 enteropathogenic
E. coli (EPEC) and 24 non-STEC/EPEC E. coli.
Genetic diversity of STEC isolates
To reveal the genetic diversity of the STEC isolates of this study,
median pairwise distance (MPD) was calculated [26] and the MPD
was compared to that of two other independent strain collections,
i.e. 76 isolates of the DEC collection and 131 isolates that were
randomly selected from a collection of extended-spectrum b-Fig. 2. Comparison of virulence genes in eae-positive and eae-negative STEC isolates. Blue
isolates, respectively. *p <0.05, **p <0.001.lactamaseeproducing Enterobacteriaceae (ESBL-E) from a multi-
centre study on the epidemiology of ESBL-E in Dutch hospitalized
patients (SoM study, unpublished data). Because neither of the
underlying population followed normal distribution pattern, the
median of the pairwise distances and interquartile ranges (IQR)
were calculated in all three populations. To identify the group dif-
ferences onMPD of three E. coli isolates, the Kruskal-Wallis test was
used. Additionally, to compare the genetic diversity within the STEC
isolates with that of other E. coli populations, the Mann-Whitney U
test was performed, and the statistical signiﬁcance level was cor-
rected by Bonferroni correction for multiple testing.
Results
STEC isolates and patient groups
From 425 stx-positive faecal samples, 132 STEC isolates (Gro-
ningen, n ¼ 70; Rotterdam, n ¼ 62) from 129 patients were ob-
tained. From three patients, two different types of STEC were
isolated. Characteristics of the isolates are summarized in
Supplementary Table S1. On the basis of clinical outcomes (avail-
able for 110 patients), patients were classiﬁed into groups with
bloody diarrhoea (including one haemolytic-uremic syndrome
patient) (n ¼ 26), nonbloody diarrhoea (n ¼ 64) and no diarrhoea
(n ¼ 20) but having other clinical symptoms, such as abdominal
pain, nausea and malaise (Supplementary Table S1).and red bars represent frequency of virulence genes in eae-positive and eae-negative
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Forty-two different serogenotypes and 44 different STs were
found among the 132 isolates. The most predominant serogeno-
typeswereO91:H14 (n¼19), O157:H7 (n¼17) andO26:H11 (n¼15)
(Fig.1a). Themost predominant STswere ST33 (n¼19), ST11 (n¼17)
and ST21 (n ¼ 17) (Fig. 1b). For six of the isolates, we found new STs
assigned by EnteroBase database (Supplementary Table S1). Four-
teen different stx subtypes (combinations) were found among the
isolates, with stx1a beingmost predominant (n¼ 55, 41.6%) (Fig.1c).
Almost all O91:H14 isolates contained only the stx1a gene except
two, of which one (STEC 2620) contained the stx1a þ stx2b, and the
other (STEC 2110-1) contained only the stx2a gene (Supplementary
Table S1). One stx2-positive isolate (STEC 2826) had both stx2d
(encoding Stx A subunit) and stx2a (encoding Stx B subunit) genes.Presence of virulence genes
Among the eae-positive isolates (n¼ 71), 33 (46%) contained stx1,
21 (30%) contained stx2, 16 (23%) contained stx1 þ stx2 and oneTable 1
Distribution of virulence genes (other than stx) among isolates obtained from three pati
Virulence gene category Virulence gene Patient group, n (%)
BD (n ¼ 26) NBD (n ¼ 64)
eae 21 (80) 34 (53)
tir 21 (80) 34 (53)
espB 18 (69) 24 (37.5)
iha 14 (54) 36 (56)
efa1 11 (42) 18 (28)
saa 1 (4) 2 (3)
Toxin ehxA 24 (92) 41 (64)
toxB 12 (46) 15 (23)
astA 17 (65) 26 (41)
subA 2 (8) 10 (15.6)
cnf1 0 (0) 1 (1.6)
cdtB 0 (0) 1 (1.6)
senB 1 (4) 5 (8)
Secretion system espA 21 (80) 33 (51)
espC 1 (3.8) 3 (4.7)
espF 19 (73) 27 (42)
espI 3 (11.5) 8 (12.5)
espJ 21 (80) 33 (51)
nleA 20 (77) 27 (42)
nleB 19 (73) 30 (47)
nleC 16 (61.5) 22 (34)
etpD 12 (46) 15 (43)
cif 12 (46) 26 (40.6)
tccP 2 (8) 13 (20)
SPATE espP 16 (61.5) 23 (36)
pic 1 (4) 4 (6)
sepA 1 (4) 2 (3)
sigA 1 (4) 5 (8)
Colicin cma 3 (11.5) 3 (4.7)
cba 7 (27) 12 (19)
celb 6 (23) 17 (26.6)
Microcin mchB 4 (15) 13 (20)
mchC 4 (15) 13 (20)
mchF 6 (23) 17 (26)
mcmA 1 (4) 1 (1.6)
Fimbriae lpfA 20 (77) 44 (69)
Other ireA 3 (11.5) 14 (22)
katP 10 (38.5) 22 (34)
BD, bloody diarrhoea; CI, conﬁdence interval; NBD, nonbloody diarrhoea; ND, no diarrh
*Statistically signiﬁcant p values.
a p values were obtained by chi-square test comparing three groups.
b OR obtained from binary logistic regression. OR was also calculated for group D vs. Nisolate was found without the stx gene. Among the eae-negative
isolates (n¼ 61), the prevalence of stx1, stx2 and stx1þ stx2epositive
isolates was 49% (n ¼ 30), 26% (n ¼ 16) and 24.5% (n ¼ 15), respec-
tively. In eae-positive isolates, the virulence genes tir, espA, espB, espF,
espJ, espP, nleA, nleB, nleC, etpD, katP, toxB, efa1 and cif were signiﬁ-
cantlymore oftenpresent,whereas iha,mchB,mchC,mchF, subA, ireA,
sepA, senB, saa and sigA geneswere signiﬁcantlymore often found in
eae-negative isolates (Fig. 2). The associations and the effects (odds
ratios and their conﬁdence intervals) of the presence of virulence
genes with bloody diarrhoea and diarrhoea are presented in Table 1.Antibiotic resistance patterns and presence of resistance genes
Phenotypic antibiotic resistance patterns of the isolates are
shown in Supplementary Table S3. In 33 STEC isolates (25%), at least
one antibiotic resistance gene was found. Although not statistically
signiﬁcant, the presence of resistance genes was higher in only
stx1-positive isolates (35.5%) compared to stx2 (16.5%) (p 0.063)-
and stx1 þ stx2 (15%) (p 0.054)-positive isolates. Antibiotic resis-
tance genes found in STEC isolates are listed in Table 2. Two isolatesent groups
pa ORb (95% CI)
ND (n ¼ 20) BD vs. NBD BD vs. ND
7 (35) 0.006* 3.7 (1.24e11.04) 7.8 (2.04e29.7)
7 (35) 0.006* 3.7 (1.2e11.04) 7.8 (2.04e29.7)
6 (30) 0.009* 3.7 (1.4e9.9) 5.2 (1.4e18.6)
15 (75) 0.272 0.9 (0.36e2.2) 0.39 (0.11e1.38)
4 (20) 0.231 1.87 (0.72e4.8) 2.93 (0.76e11.2)
1 (5) 0.924 1.24 (0.10e14.3) 0.76 (0.04e12.9)
13 (65) 0.023* 6.7 (1.4e31) 6.4 (1.1e35.7)
4 (20) 0.063 2.8 (1.06e7.3) 3.4 (0.89e13)
7 (35) 0.059 2.7 (1.06e7.13) 3.5 (1.03e11.9)
5 (25) 0.273 0.45 (0.92e2.21) 0.25 (0.04e1.45)
0 (0) 0.696 Undeﬁned Undeﬁned
1 (5) 0.441 Undeﬁned Undeﬁned
2 (10) 0.704 0.47 (0.05e4.2) 0.36 (0.03e4.28)
7 (35) 0.005* 3.9 (1.3e11.7) 7.8 (2.04e29.7)
0 (0) 0.619 0.81 (0.08e8.19) Undeﬁned
5 (25) 0.003* 3.7 (1.3e10) 8.1 (2.1e30.8)
2 (10) 0.954 0.91 (0.22e3.75) 1.17 (0.18e7.8)
6 (30) 0.002* 3.9 (1.3e11.7) 9.8 (2.5e38.4)
6 (30) 0.002* 4.5 (1.6e12.9) 7.7 (2.07e29.1)
6 (30) 0.011* 3.07 (1.1e8.3) 6.3 (1.7e23)
6 (30) 0.035* 3.05 (1.1e7.8) 3.7 (1.08e12.9)
1 (5) 0.005* 2.8 (1.06e7.3) 16.2 (1.8e140)
6 (30) 0.534 1.25 (0.50e3.13) 2.00 (0.58e6.83)
1 (5) 0.125 0.33 (0.06e1.56) 1.58 (0.13e18.8)
6 (30) 0.045* 2.8 (1.1e7.3) 3.7 (1.08e12.9)
0 (0) 0.494 0.60 (0.06e5.63) Undeﬁned
0 (0) 0.69 1.24 (0.10e14.2) Undeﬁned
3 (15) 0.387 0.47 (0.05e4.24) 0.22 (0.02e2.36)
1 (5) 0.465 2.65 (0.49e14) 2.47 (0.23e25.8)
5 (25) 0.648 1.6 (0.54e4.65) 1.10 (0.29e4.19)
5 (25) 0.941 0.83 (0.28e2.41) 0.9 (0.23e3.51)
8 (40) 0.110 0.71 (0.21e2.43) 0.27 (0.06e1.1)
8 (40) 0.110 0.71 (0.21e2.43) 0.27 (0.06e1.1)
8 (40) 0.407 0.83 (0.28e2.41) 0.45 (0.12e1.61)
1 (5) 0.657 2.5 (0.15e41.8) 0.76 (0.04e12.9)
17 (85) 0.323 1.51 (0.53e4.34) 0.59 (0.12e2.71)
8 (40) 0.071 0.46 (0.12e1.78) 0.19 (.04-.87)
4 (20) 0.379 1.12 (0.46e3.06) 2.5 (0.64e9.6)
oea; OR, odds ratio.
D but was found to be not signiﬁcant and therefore is not mentioned in this table.
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ESBL producers and contained the blaCTX-M-15 and blaCTX-M-1
genes, respectively.Phylogenetic analysis
The core genome phylogenetic tree was constructed including
those 2069 genes (deﬁned as core genome) shared by all 137
isolates, including ﬁve reference STEC isolates (Fig. 3). To describe
the isolates from the tree, the NJ tree in Fig. 3 is arbitrarily divided
into eight groups (groups 1 to 8). Isolates of the same serogeno-
type or ST are clustered together, irrespective of their stx subtypes
and isolation region (Groningen or Rotterdam). Group 2, 4, 5 and 7
contained isolates of serogenotypes O157:H7, O26:H11, O91:H14
and O103:H2, respectively, which were the most prevalent sero-
genotypes in this study. In group 7, isolates of serotype O128:H2
formed a subcluster. Groups 3 and 6 contained heterogeneous
isolates of different STs and serogenotypes. All but one (STEC 309,
in group 7) of the stx 2f-positive isolates clustered together (in
group 1) and belonged to O63:H6 and O113:H6 serogenotypes
(Fig. 3).
Several subclusters were observed in a single STcluster. In group
4, isolates of serogenotype O26:H11 formed different subclusters
within ST21; notably, one of the subclusters contained three
O69:H11 isolates which had a 290 minimum allele difference (data
not shown) from their closest O26:H11 isolate STEC 380. In some
cases, isolates from the same O serogroups, e.g. O5:H9 and O5:H19,
were found to be scattered at distinct positions in the tree. On the
other hand, most of the casesdisolates of the same H type, irre-
spective of their O serotypesdshared a common ancestor, e.g.Table 2
Presence of antibiotic resistance genes in STEC isolates
Isolate ID Serogenotype stx subtype
STEC 168 O91:H14 stx1a
STEC 169 O6:H10 stx1c
STEC 196 O91:H14 stx1a
STEC 200 O174:H21 stx2c
STEC 299 O5:H9 stx1a
STEC 329 O91:H14 stx1a
STEC 338 O104:H4 stx2a
STEC 370 O111:H8 stx1a
STEC 381-1 O104:H4 stx2a
STEC 381-4 O104:H4 stx2a
STEC 479 O26:H11 stx1a
STEC 487 O26:H11 stx1a
STEC 690 O69:H11 stx1a
STEC 691 O69:H11 stx1a
STEC 757 O69:H11 stx1a
STEC 1255 O5:H9 stx1aþ stx2a
STEC 1500 O76:H19 stx1c
STEC 1585 O91:H14 stx1a
STEC 2193 O103:H2 stx1a
STEC 2236 O113:H4 stx2d
STEC 2359 O55:H12 stx1a
STEC 2441 O5:H9 stx1a
STEC 2564 O117:H7 stx1a
STEC 2573 O112:H19 stx1aþ stx2d
STEC 2633 O146:H10 stx1a
STEC 2743 O103:H2 stx1a
STEC 2770 O157:H7 stx1aþ stx2c
STEC 2797 O100:H30 stx2e
STEC 2820 O157:H7 stx1aþ stx2c
STEC 2821 O157:H7 stx1aþ stx2c
STEC 3084 O91:H14 stx1a
STEC 3087 O91:H14 stx1a
STEC 3106 O91:H14 stx1a
STEC, Shiga toxineproducing Escherichia coli.serogroups O103:H2 and O128:H2; serogroups O174:H21,
O146:H21 and O91:H21; and serogroups O113:H6 and O63:H6.
To reveal the genetic relatedness of the isolates based on their
virulence genes and other mobile genetic elements, an additional
NJ tree was constructed. This tree was based on the accessory
genome containing 2586 genes that were present in at least one
isolate but not in all of the 137 isolates (Supplementary Fig. S1). The
treewas almost identical to the core genome phylogenetic tree, and
no clusters based on disease severity were found.Distribution of isolates with clinical manifestation, geographical
location and epidemiologic link
The isolates obtained from the patients with bloody diarrhoea
belonged to different serogenotypes and STs (Fig. 3). No signiﬁcant
geographical distribution was observed among the STEC isolates in
relation to their genotypes. Two exceptions should be mentioned
within group 6, in which all four isolates belonging to ST442 were
obtained from patients in the Rotterdam region. In addition, in
group 1, seven of nine stx2f isolates were obtained from patients in
the Groningen region. All other closely related subclusters con-
tained isolates from both regions. Isolates of two clusters contain-
ing three (STEC 338, STEC 381-1 and STEC 381-4 in group 6) and
two (STEC 690 and STEC 757 in group 4) epidemiologically related
isolates were also closely genetically related. In Fig. 3, we also
highlight isolates having almost similar core genomes, e.g. STEC
563 and STEC 709 (three-allele difference), STEC 479 and STEC 487
(no allele difference), STEC 2174 and STEC 2363 (one-allele differ-
ence), STEC 384 and STEC 464 (no allele difference), and STEC 299
and STEC 2441 (two-allele difference); for those isolates, noPresence of antibiotic resistance genes
dfrA1, strA-B, sul2
aadA1, blaTEM-1B, dfrA1, mphB, strA-B, sul1e2, tetA
aadA1, sul1, tetA
strA-B, sul2, tetB
strA-B, sul2
aadA5, catB3, dfrA1, sul1, tetA
blaTEM-1B, dfrA7, sul1
aadA1, aph(30)-Ia, catA, dfrA1, mphB, strA-B, sul1, tetA, tetM
bla CTX-M-15, blaTEM-1B, dfrA7, sul1
blaTEM-1B, dfrA7, sul1
aadA1, blaTEM-1B, dfrA1, mphB, strA-B, sul1e2, tetA
aadA1, blaTEM-1B, dfrA1, mphB, strA-B, sul1e2, tetA
aac(3)-IIa, aadA1, aph(30)-Ic, blaTEM-1A, catA1, dfrA1, mphB, strA-B, sul1e2, tetA-B
aac(3)-IIa, aadA1, aph(30)-Ic, blaTEM-1A, catA1, dfrA1, mphB, strA-B, sul1e2, tetA-B
aac(3)-IIa, aadA1, aph(30)-Ic, blaTEM-1A, catA1, dfrA1, mphB, strA-B, sul1e2, tetA-B
blaCTX-M-1, mphA
strA-B
aadA1, sul1, tetA
blaTEM-1C, strA-B, sul2
strA-B, sul2, tetB
blaTEM-1B, strA-B, sul2, tetA
strA-B, sul2
dfrA14, strA-B, sul2, tetA
blaTEM-1B, catA, ﬂoR, strA-B,sul2, tetA
aadA1, sul1, tetA
aadA1, blaTEM-1B, dfrA1, strA-B, sul1e2, tetA
blaTEM-1B, strA-B, sul2, tetA
aadA1, blaTEM-1B, dfrA1, strA-B, sul1e2, tetA
aadA1, aph(30)-Ia, blaTEM-1B, dfrA8, strA-B, sul2, tetA
blaTEM-1B, strA-B, sul2, tetA
aadA5, catB, dfrA1, sul1, tetA
aadA5, catB, dfrA1, sul1, tetA
tetA
Fig. 3. Neighbour-joining (NJ) phylogenetic tree of STEC isolates based on 2069 genes (deﬁned as core genome) shared by 137 STEC isolates (including ﬁve reference STEC). Whole
tree is arbitrarily divided into eight groups, indicated by circles (groups 1 to 8). Predominant serogenotypes are mentioned in circles. Each isolate ID is followed by isolation region
(G for Groningen and R for Rotterdam), serogenotype, sequence type and stx subtype. Closely related isolates with allele difference <5 (obtained from minimum spanning tree
analysis) are highlighted with red lines behind them. New sequence types were not updated in Seqsphere server during analysis and therefore were left as ‘?’ as unknown ST. ST,
sequence type; STEC, Shiga toxineproducing Escherichia coli.
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Fig. 4. Neighbour-joining (NJ) phylogenetic tree of STEC isolates and DEC reference isolates based on 1231 genes (deﬁned as core genome) shared by 208 isolates. Non-STEC isolates
are marked with red asterisk. For each isolate, serogenotypes and sequence types are provided behind isolate name. DEC, diarrhoeagenic Escherichia coli; STEC, Shiga tox-
ineproducing E. coli.
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was obtained from MST analyses (data not shown).
Phylogenetic comparison of STEC isolates with DEC reference
collection
Figure 4 shows a NJ tree representing all the STEC isolates from
this study and E. coli isolates from the DEC collection. STEC isolates
of this study represented a diverse collection and did not form a
separate cluster but were interspersed among the DEC isolates.
The phylogenetic tree shows that STEC serogroups O157:H7
evolved from E. coli O55:H7 isolates (DEC5) and O26:H11 clustered
with DEC9 and DEC10 isolates in a separate lineage. In both cases,
clusters contained only STEC isolates. In contrast, STEC O103:H2
shared a common ancestor with EPEC O111:H2 (DEC12) andO128:H2 (DEC11AeD). STEC O63:H6 and O113:H6, both belonging
to the stx2f subtype, shared a common ancestor with EPEC
O55:H6 (DEC1 and DEC2). Among the non-STEC/EPEC isolates,
DEC13, DEC14 and DEC15 isolates shared a common ancestor with
several of our STEC isolates of heterogeneous serotypes, and DEC6
(O111:H21) isolates clustered together with our STEC ST10
isolates.
Genetic diversity of STEC isolates compared to DEC isolates and
ESBL-producing E. coli isolates
The MPD of the STEC, DEC and ESBL-producing E. coli isolates
was 0.86 (IQR 0.24), 0.93 (IQR 0.24) and 0.97 (IQR 0.10), respec-
tively. The result from the Kruskal-Wallis test indicated that the
MPD of the three populations (STEC, DEC and ESBL) was
M. Ferdous et al. / Clinical Microbiology and Infection 22 (2016) 642.e1e642.e9 642.e8signiﬁcantly different (p <0.001). Additionally, a Mann-Whitney U
test showed that there was a highly signiﬁcant difference (p
<0.001) between the MPD of STEC and ESBL, and DEC and ESBL (p
<0.001), but not between the MPD of STEC and DEC (p 0.137).
Discussion
In this study, STEC isolates were collected from faecal samples of
patients with gastrointestinal complaints from two regions of the
Netherlands. Molecular characterization and high-resolution
typing of the isolates was performed using WGS. Serogenotyping,
MLST and subtyping of stx genes revealed a diverse group of STEC in
the study population. Twenty-ﬁve per cent of the isolates carried
one or more antibiotic resistance genes, including ESBL genes.
Resistance genes were mostly found in stx1-positive isolates
belonging to O serotypes other than the big six known to be most
frequently involved in severe human infection. These isolates often
originate from food-producing animals, which are regularly treated
with antibiotics that may lead to STEC becoming resistant. In
addition, stx1-positive bacteria often cause only mild symptoms
without bloody diarrhoea, and patients may receive antibiotic
therapy if no detailed diagnostics is performed [27e29]. Recently,
several reports, including that of on the 2011 German E. coli
O104:H4 outbreak, have described the association of STEC isolates
with ESBL genes [30]. Antibiotic resistance genes are mainly carried
on mobile genetic elements that can be transferred from one bac-
terium to the other while subjected to selective pressure, e.g. by
exposure to antibiotics. Transferring of resistance genes into clini-
cally signiﬁcant bacteria for human could make their treatment
option complicated [31].
The presence of several virulence genes (iha, mchB, mchC, mchF,
subA, ireA, senB, saa, sigA) was signiﬁcantly higher in eae-negative
isolates compared to eae-positive ones, similar to that reported by
previous studies in which these genes were described as additional
virulence factors in eae-negative strains [32,33]. The presence of
virulence genes (eae, tir, espA, espF, espJ) associated with the LEE
pathogenicity island and the non-LEE-encoded effector (nle) that
encodes translocated substrates of the type III secretion systemwas
more frequent in isolates obtained from patients with bloody diar-
rhoea. These genetic determinants were also described to be asso-
ciated with highly pathogenic STEC and therefore with severe
disease [15,34], although a wide number of STEC LEE-negative
strains also have been associated with sporadic cases and out-
breaks [4]. There was no correlation between the serogenotype or
STs and disease outcome. Thus, isolates obtained from bloody diar-
rhoea did not belong to a speciﬁc phylogenetic cluster but were
scattered throughout the phylogenetic tree. This ﬁnding supports
the idea that STEC fromdifferent phylogenetic backgrounds could be
responsible for severe disease outcome in human by acquiring
virulence factors contributing to their pathogenicity [15]. Further-
more, clustering of isolates according to their STs and serogenotype
pattern irrespective of stx subtypes suggests that Stx-converting
phages are carried by a genetically diverse group of E. coli [35]. In
addition, thephylogenetic tree basedon the accessorygenomeof the
isolates also showed no correlation with disease severity. Clearly,
disease outcome is multifactorial and does not only depend on the
genetic contents or virulence factors of the isolates but also on host
susceptibility factors and several Stx phage-related factors [36].
MLST provides an adequate tool for producing genetic proﬁles
for a vast number of isolates, especially in nonepidemic circum-
stances, i.e. for national reference services or when comparing large
international strain collections, but it has a low discriminatory
power. We found several subclusters within the same ST and
serogenotype clusters. In addition, isolates highly similar in their
core genomewere also identiﬁed by cgMLST. Five historical isolatesobtained from outbreaks or sporadic cases were included in the
phylogeny, andwe found that two of our O157:H7 isolates clustered
with two O157:H7 isolates associated with a previous outbreak [18]
and that three epidemiologically related O104:H4 isolates clustered
with the 2011 E. coli O104:H4 outbreak isolate 2011c-3493 [24].
Therefore, the detailed gene-by-gene phylogenetic approach using
cgMLST enabled us to discriminate among isolates within the same
STs and helped us to identify potentially more virulent clones,
thereby improving risk assessment and outbreak management.
Isolates belonging to different serogroups clustered with each
other, suggesting that using just serogroups may cause misleading
conclusions about the phylogenetic relatedness between STEC
strains and their health risks [37]. However, the two regions
(Groningen and Rotterdam) fromwhich the isolates were obtained
are only approximately 250 km away, and both regions probably
share many food sources. This may be an explanation for why no
geographical distribution was observed among the STEC isolates of
the different regions. In some cases, isolates of the same O
serogroup were located in different phylogenetic clusters. On the
other hand, isolates of the same H type, irrespective of their O
serotype, shared a common ancestor. This ﬁnding is in concordance
with previous ﬁndings where H serogroups were described as
monophyletic, whereas O serogroups were described as poly-
phyletic [37,38].
Comparing STEC isolates of this studywith DEC isolates revealed
that the STEC isolates represent a heterogeneous group. Some of
the serogroups formed distinct branches containing only STEC
isolates. However, some serogroups shared a common ancestor
with EPEC and other stx/eae-negative DEC isolates. This supports
the hypothesis that Stx converting bacteriophages can integrate
into different E. coli pathogroups, thereby converting them into a
more pathogenic variants [33]. Moreover, STEC isolates of this study
had a similar diversity pattern compared to DEC isolates but were
less diverse than ESBL-producing E. coli isolates. This result sup-
ports the idea that Stx converting bacteriophages may have a
preference in host selection [36].
Our study has several limitations. Firstly, it was not possible to
link all the isolate characteristics with patient disease outcome and
epidemiology as a result of the lack of patient information. There-
fore, an unknown epidemiologic linkage may exist among isolates,
which might have inﬂuenced the reported diversity. Moreover, as
some of the faecal samples were also positive for parasites, and
other bacteria causing gastroenteritis and all samples were not
tested for gastroenteric viruses, it was not possible to elucidate the
exact aetiology of the disease outcome.
In conclusion, STEC isolates of a substantial genetic diversity and
of distinct phylogenetic groups were observed in two regions of the
Netherlands. WGS serves perfectly well for detailed characteriza-
tion of STEC strains compared to serotyping and MLST, which have
less discriminatory power and which do not provide any informa-
tion on virulence and resistance genes.WGS of STEC could be useful
for outbreak tracing within a clinical outbreak, but because STEC
strains are diverse, it may not always be suitable for comparing
different outbreaks. WGSmay not always be useful to ﬁnd common
ancestors of STEC because of its great heterogeneity and incorpo-
ration of mobile genetic elements, but so far, it is the best available
method. There was no clear correlation between serogenotype, stx
subtype or ST and disease outcome, as it is also inﬂuenced by
several factors in addition to virulence factors or a speciﬁc
pathotype.
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